Google Moonshot Targets Disease Management, but Might Face Obstacle with Google Management Methods
May 17, 2016
The article on STAT titled Google’s Bold Bid to Transform Medicine Hits Turbulence Under a Divisive CEO explores Google management methods for one of its “moonshot” projects. Namely, the massive company has directed its considerable resources toward overhauling medicine. Verily Life Sciences is the three year-old startup with a mysterious mission and a controversial leader in Andrew Conrad. So far, roughly a dozen Verily players have abandoned the project.
“But “if they are getting off the roller coaster before it gets to the first dip,” something looks seriously wrong, said Rob Enderle, a technology analyst who has tracked Google since its inception. Those who depart well-financed startups usually forsake potential financial windfalls down the line, which further suggests that the people leaving Verily “are losing confidence in the leadership,” he said. No similar brain drain has occurred at Calico, another ambitious Google spinoff, which is focused on increasing the human lifespan.”
Given the scope of the Verily project, which Sergey Brin, Google co-founder, announced that he hoped would significantly change the way we identify, avoid, and handle illness, perhaps Conrad is cracking under the stress. He has maintained complete radio silence and rumors abound that his employees operate under threat of termination for speaking to a reporter.
Chelsea Kerwin, May 17, 2016
Sponsored by ArnoldIT.com, publisher of the CyberOSINT monograph
Comments
-
- Subscribe to Beyond Search
Feature archive
News archive
-
